Integrating Asciminib into the Evolving Treatment Landscape of Chronic Myeloid Leukemia: A Canadian Perspective
Journal of Blood Medicine · 2026-09 · Volume 17 · 1-17
DOI: 10.2147/jbm.s627651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Blood Medicine, 2026-09. Verfasst von Dennis Dong Hwan Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
- Institut Universitaire d'Hémato-Oncologie et de Thérapie Cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
- Groupe Québécois de recherche en LMC-NMP, Montréal, QC, Canada.
- Department of Oncology, McMaster University, Hamilton, ON, Canada.
- Department of Hematology, McGill University Health Centre, Montréal, QC, Canada.
- Department of Medicine, University of Calgary, Calgary, AB, Canada.
Zitieren
APA
Kim, D. D. H., Busque, L., Hillis, C., Laneuville, P., & Savoie, M. L. (2026). Integrating Asciminib into the Evolving Treatment Landscape of Chronic Myeloid Leukemia: A Canadian Perspective. Journal of Blood Medicine, Volume 17, 1-17. https://doi.org/10.2147/jbm.s627651
Vancouver
Kim DDH, Busque L, Hillis C, Laneuville P, Savoie ML. Integrating Asciminib into the Evolving Treatment Landscape of Chronic Myeloid Leukemia: A Canadian Perspective. Journal of Blood Medicine. 2026;Volume 17:1-17. doi:10.2147/jbm.s627651
BibTeX
@article{Kim2026,
author = {Kim, Dennis Dong Hwan and Busque, Lambert and Hillis, Christopher and Laneuville, Pierre and Savoie, Mary Lynn},
title = {Integrating Asciminib into the Evolving Treatment Landscape of Chronic Myeloid Leukemia: A Canadian Perspective},
journal = {Journal of Blood Medicine},
year = {2026},
volume = {Volume 17},
pages = {1--17},
doi = {10.2147/jbm.s627651}
}
EUVIMED